BioAnalytix, Inc., 790 Memorial Drive, Cambridge, Massachusetts 02139, United States.
Anal Chem. 2020 Jun 16;92(12):8306-8314. doi: 10.1021/acs.analchem.0c00661. Epub 2020 Jun 2.
Characterization of the higher-order structures in idursulfase (iduronate-2-sulfatase, I2S) has been accomplished through the use of hydrogen-deuterium exchange mass spectrometry (HDX-MS). The method has over 97% sequence coverage, including seven of the eight glycosylation sites, and has been used to study the impact of glycosylation on backbone proton exchange. In addition, the method adapted a well-used biophysical spectra comparison method (similarity scoring) to define quantitative acceptance criteria for analytical comparability of different batches of drug substance as well as samples with modulated glycans. Differences in the HDX profile were induced by enzymatic removal of terminal sialic and phosphate groups on negatively charged glycans. These differences were mapped to the crystal structure and demonstrated synergistic HDX changes focused around the N221 and N255 glycosylation sites, which contain mannose-6-phosphate motifs important for I2S uptake into cells.
通过使用氢氘交换质谱(HDX-MS)技术,对艾杜糖-2-硫酸酯酶(iduronate-2-sulfatase,I2S)的高级结构进行了表征。该方法的序列覆盖率超过 97%,包括 8 个糖基化位点中的 7 个,并且已用于研究糖基化对骨架质子交换的影响。此外,该方法采用了一种广泛使用的生物物理谱比较方法(相似性评分),为不同批次药物物质以及具有调制聚糖的样品的分析可比性定义了定量接受标准。通过酶促去除带负电荷聚糖末端的唾液酸和磷酸基团,诱导 HDX 谱的差异。这些差异被映射到晶体结构上,并证明了 N221 和 N255 糖基化位点周围的协同 HDX 变化,这些位点包含对 I2S 进入细胞摄取至关重要的甘露糖-6-磷酸基序。